Benzinga’s Volume Movers (MAPP, RICK, VOLC, PRXL, AMAG)
MAP Pharmaceuticals Inc (NASDAQ: MAPP) shares have jumped by 29.93% to $12.46. The volume of MAPP shares traded was 1230% higher than normal. MAPP informed that the FDA does not require the company to run a new effectiveness study on its migraine drug candidate Levadex.
Rick's Cabaret International Inc (NASDAQ: RICK) shares have risen 8.07% to $11.25. The volume of RICK shares traded was 736% higher than normal. Brean Murray has initiated coverage of RICK with a “buy” rating.
Volcano Corporation (NASDAQ: VOLC) shares have gained 7.31% to $19.97. The volume of VOLC shares traded was 345% higher than normal. VOLC expects to post its Q4 revenues higher than the consensus.
PAREXEL International Corporation (NASDAQ: PRXL) shares have climbed 10.45% to $17.01. The volume of PRXL shares traded was 326% higher than normal. PRXL has raised its earnings and service revenue guidance for Q2 and FY10.
AMAG Pharmaceuticals Inc (NASDAQ: AMAG) shares have surged 17.71% to $47.60. The volume of AMAG shares traded was 231% higher than normal. AMAG has indicated that it expects to its sales for Q4 at $13 million, driven by higher-than-expected sales of its key Feraheme drug.
